Clinical Outcomes and Safety of Transfemoral Aortic Valve Implantation Under General Versus Local Anesthesia
Authors:
- Atsushi OguriAOAtsushi Oguri
- Masanori YamamotoMYMasanori Yamamoto
- Gauthier MouilletGMGauthier Mouillet
- Martine GilardMGMartine Gilard
- Marc LaskarMLMarc Laskar
- Helene EltchaninoffHEHelene Eltchaninoff
- Jean FajadetJFJean Fajadet
- Bernard IungBIBernard Iung
- Patrick Donzeau-GougePDPatrick Donzeau-Gouge
- Pascal LeprincePLPascal Leprince
- Alain LeguerrierALAlain Leguerrier
- Alain PratAPAlain Prat
- 1 August 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 7 (4) , 602-610
Abstract
Background—: Transcatheter aortic valve implantation (TAVI) performed under local anesthesia (LA) is becoming increasingly common. We aimed to compare the clinical outcomes in patients who underwent transfemoral-TAVI under general anesthesia (GA) and LA. Methods and Results—: Data from 2326 patients in the French Aortic National CoreValve and Edwards 2 (FRANCE 2) registry who underwent transfemoral-TAVI were analyzed. During the study period, the percentage of LA procedures increased gradually from 14% in January 2010 to 59% in October 2011. The clinical outcomes for GA (n=1377) and LA (n=949) were compared. Numerous baseline characteristics differed between the 2 groups, and the use of transesophageal echocardiographic guidance was more common in GA than in LA (76.3% versus 16.9%; P P =0.41 and 91.6% versus 91.3%; P =0.69, respectively), whereas the incidence of postprocedural aortic regurgitation≥mild was significantly lower in GA than in LA (15.0% versus 19.1%; P =0.015). The groups were also analyzed using a propensity-matching model, including transesophageal echocardiographic usage (GA [n=401] versus LA [n=401]). This model indicated that there were no significant differences between the 2 groups in the rates of 30-day survival (GA [91.4%] versus LA [89.3%]; P =0.27] and postprocedural aortic regurgitation≥mild (GA [12.7%] versus LA [16.2%]; P =0.19). Conclusions—: The less invasive transfemoral-TAVI under LA is preferred in clinical settings and seems to be acceptable; however, the higher incidence of postprocedural aortic regurgitation is emphasized. Therapeutic efforts should be made to reduce such complications during transfemoral-TAVI under LA.Keywords
This publication has 27 references indexed in Scilit:
- Anesthesia and Perioperative Management of Patients Undergoing Transcatheter Aortic Valve Implantation: Analysis of 90 Consecutive Patients With Focus on Perioperative ComplicationsJournal of Cardiothoracic and Vascular Anesthesia, 2010
- Transcatheter Aortic Valve ImplantationCirculation, 2009
- Outcomes and Safety of Percutaneous Aortic Valve ReplacementJACC, 2009
- Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving SystemCirculation: Cardiovascular Interventions, 2008
- Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approvalEuroIntervention, 2008
- Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosisThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic StenosisCirculation, 2007
- Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third-Generation Self-Expanding CoreValve ProsthesisJACC, 2007
- Treatment of Calcific Aortic Stenosis With the Percutaneous Heart ValveJACC, 2006
- Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic StenosisCirculation, 2002